Industry News
Acute chest syndrome development associated with hemin and sickle cell disease
Oct 03, 2013
Acute chest syndrome (ACS) is a complication of sickle cell disease that is characterized by sudden pain and difficulty breathing. Sickle cell disease can also cause red blood cells to suddenly breakdown and release their contents, which may trigger the onset of ACS... Read More
Melanoma patients increase sun exposure after diagnosis
Oct 02, 2013
Researchers have discovered that patients with melanoma throw caution to the wind in the 3 years following their diagnoses and increase the amount of time they spend in the sun. According to the American Academy of Family Physicians, cutaneous malignant melanoma (CMM) is a potentially lethal skin cancer... Read More
Melanoma patients increase sun exposure after diagnosis
Oct 02, 2013
Researchers have discovered that patients with melanoma throw caution to the wind in the 3 years following their diagnoses and increase the amount of time they spend in the sun. According to the American Academy of Family Physicians, cutaneous malignant melanoma (CMM) is a potentially lethal skin cancer... Read More
Investigational lung cancer treatment shows strong anti-tumour activity in brain mestastases
Oct 02, 2013
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) has announced updated clinical results on its investigational tyrosine kinase inhibitor (TKI), AP26113, in patients with advanced non-small cell lung cancer (NSCLC) from an ongoing Phase 1/2 trial... Read More
Investigational lung cancer treatment shows strong anti-tumour activity in brain mestastases
Oct 02, 2013
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) has announced updated clinical results on its investigational tyrosine kinase inhibitor (TKI), AP26113, in patients with advanced non-small cell lung cancer (NSCLC) from an ongoing Phase 1/2 trial... Read More
Next generation sequencing test developed at UPMC improves detection of thyroid cancer, reduces unnecessary surgeries
Oct 02, 2013
A new test for genetic markers that can identify which lumps in the thyroid gland are cancerous and which are harmless - potentially preventing unneeded operations - will make its debut Oct. 1 for patients seeking care at the UPMC/UPCI Multidisciplinary Thyroid Center (MTC)... Read More
Castle Biosciences launches tissue repository for eye cancer patients
Oct 02, 2013
Castle Biosciences Inc. has announced the availability of a tumor tissue repository for patients whose tumors are being tested with the Company's gene test for uveal, or ocular, melanoma. Patients will now have the option of storing an additional sample of their tumor free of charge for up to five years, and will be able to access it to take advantage of future developments in the disease... Read More
More research urged to compare and validate genomic tests for patients with early breast cancer
Oct 02, 2013
The European Society for Medical Oncology (ESMO) has welcomed preliminary clinical trial results that suggest genomic testing could allow many patients with early breast cancer to safely avoid chemotherapy... Read More
Study demonstrates significant clinical and economic impact of Nanosphere's Verigene blood culture test
Oct 02, 2013
Nanosphere, Inc... Read More
Dealing with side-effects of hormone therapy for prostate cancer
Oct 02, 2013
Flushed face, sweating, a sudden rush of heat. The hot flash, the bane of menopausal women, also can affect men who are undergoing hormone therapy for prostate cancer. But unlike in women, neither soy protein nor a common antidepressant provides relief for men, according to researchers at Wake Forest Baptist Medical Center... Read More
Previous Page Next Page